feed,title,long_url,short_url
Benzinga,"Cytokinetics Records $89M Q2 Sales On Deferred Mavacamten Revenues, Forecasts FY22 Cash Of Over $800M",https://benzinga.com/general/biotech/22/08/28373373/cytokinetics-records-89m-q2-sales-on-deferred-mavacamten-revenues-forecasts-fy22-cash-of-over-800,https://bit.ly/3JAlQp2
Benzinga,"Amneal Pharma Posts Mixed Q2 Earnings, Cuts Profit Outlook For 2022",https://benzinga.com/general/biotech/22/08/28372958/amneal-pharma-posts-mixed-q2-earnings-cuts-profit-outlook-for-2022,https://bit.ly/3bAeHsu
Benzinga,"Amgen's Q2 Sales Impacted By Lower Prices, Currency Headwind, Reaffirms FY22 Outlook",https://benzinga.com/general/biotech/22/08/28372631/amgens-q2-sales-impacted-by-lower-prices-currency-headwind-reaffirms-fy22-outlook,https://bit.ly/3QhIh4C
